Page 2 - Jay Mathews News Today

A Washington Post columnist wrote that while research shows grade retention is beneficial, the education system is deeply divided over how to address academic struggles.

Barron Trump Surpasses Fathers Height, Straining Their Relationship

Four late-breaking clinical trial outcomes from The VEINS Conference presented results from the CLOUT Registry, VIVID Trial, DEXTERITY-AFP Trial, and Venous Thromboembolism Treatment were present during the The VEINS Conference, taking place Oct. 28-30 in Las Vegas, NV.

/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...

/PRNewswire/ -- Leading physicians and researchers will present results from 20 clinical trials from Monday, October 30, to Wednesday, November 1, at the...

The classic romantic comedy "Sleepless in Seattle" is celebrating its 30th anniversary. Here is a look at where some of the movie's biggest stars, including Tom Hanks and Meg Ryan, are now.

JOPLIN, Mo. — One year ago in the Gray Neighborhood of Joplin, gunshots rang out near 5th and Connor Ave. So many and so loud dozens reported hearing them.

Initial cases, proctored by 2 leading US interventionalists, mark the first use of mechanical thrombectomy for pulmonary embolism in the Republic ...

Geneva [Switzerland], May 5 (ANI/PRNewswire): The first US patient has been enrolled in the SELUTION4SFA Sirolimus DEB study by Dr Arthur Lee at the Cardiac & Vascular Institute in Florida. This study evaluates SELUTION SLR in the treatment of occlusive disease of the superficial femoral artery (SFA) and proximal popliteal artery (PPA) and has been designed to support FDA approval. It follows Investigational Device Exemption (IDE) approval in the US in August 2022. SELUTION SLR is the first ...

Local artists donate works for auction and dinner to benefit Branford Community Dining Room.